Here is a second ass-kicking-awesome rebuttal to the hack attack on $RVVTF reddit:(I will add that I prefer that MF is not talking right now. Short of a PR to all, he should not be talking to mouth pieces on reddit at this time, disclosing non public info)
JazzyJ85
·
3 hr. ago
Precedent always come from somewhere, maybe we will set it. You don’t know. I’m sure there has been tons of new “precedents” set in the last few years. Unlikely, but you can’t rule it out.
clinical team: you are assuming it’s only Kizilbash. There is no reason for you to assume that the entire team isn’t working on it… You don’t know.
Urgency of Covid: Pfizer and Merck did have to finish trials but they were rushed, half assed, and passed without knowing any side effects or long term health issues caused by it. Hence why the world signed a waiver saying they couldn’t sue them if something were to happen. No one signs a waiver like that unless you KNOW it was pushed through the FDA and trials didn’t matter. -Pre-Dose Data: they could just be taking their time to ensure they are choosing the correct end point.
210 unblinded results is a lot of records to go through. Maybe patient 1’s cough went away on day 3 but patient 2’s went away on day 10. They need find consistencies within the data across 210 patients for all 14 days. If it were as easy and giving the FDA the list and saying “see”, it would be approved by now.
Delta Health: you can’t claim them as a scam because of a website, a foreign website mind you. I went for surgery in Mexico and their website was the shits. They were professional, awesome and best in their field, but shittiest the website out there.
Majority of what you stated are your own thoughts and not DD at all. There’s no possible way for you to know who’s working on it, what communication they had, ect if MF isn’t talking. Nobody knows but RVV and it’ll likely remain that way until more news comes out.
Stay strong everyone and don’t believe everything you read. Everyone interprets what they hear/ read differently.
--------------------------
From what I just read, this could be a test, to see if RVVTF can get easy faster approval. If the FDA says no, we already know RVVTF just goes back and rewrites the end points plan and resubmits. At worst, they just finish the study.
The fact this discussion is even the topic, and is not discussion about a failed study, or bad side effects, etc, is encouraging..
So you all wait, I am buying more drama shares at the bid...
Market Data 
Markets 
AI
